Cor Vasa 2008, 50(12):465-469 | DOI: 10.33678/cor.2008.170

Current alternatives to anticoagulation therapy in patients with atrial fibrillation

Miloš Táborský*, Petr Neužil
Kardiocentrum, Nemocnice Na Homolce, Praha, Česká republika

Atrial fibrillation is the most common type of supraventricular arrhythmias. Based on formation of atrial trombi, especially in the left atrial appendage, it is associated with a significantly increased risk for developing stroke. Different medical, surgical and catheter-based methods for stroke prevention in patients with atrial fibrillation will be discussed.

Keywords: Atrial fibrillation; Left atrial appendage; Embolism

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Táborský M, Neužil P. Current alternatives to anticoagulation therapy in patients with atrial fibrillation. Cor Vasa. 2008;50(12):465-469. doi: 10.33678/cor.2008.170.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Natale A, Raviele A, Arentz T, et al. Venice chart international concensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007;18:560-80. Go to original source... Go to PubMed...
    2. Wolf PA, Abbort RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroker: the Framingham study. Stroke 1991;22:983-8. Go to original source... Go to PubMed...
    3. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: ATRIA Study. JAMA 2001;285:2370-5. Go to original source... Go to PubMed...
    4. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. JAMA 2003;290: 1049-56. Go to original source... Go to PubMed...
    5. Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-34. Go to original source...
    6. Harrison MJ, Marshall J. Atrial fibrillation, TIAs and completed strokes. Stroke 1994;15:441-2. Go to original source...
    7. Hagens VE, Crijns HJGM, van Veldhuisen DJ, et al. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RACE study. Am Heart J 2005; 149:1106-11. Go to original source... Go to PubMed...
    8. Wyse DG, Waldo AG, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. Go to original source... Go to PubMed...
    9. Hart RG, Halperin JL, Pearce LA, et al. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 2003;138:831-8. Go to original source...
    10. Levie MN, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119:108-21S. Go to original source...
    11. Waldo AL, Becker RC, Tapson VF, et al. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005;46:1729-36. Go to original source... Go to PubMed...
    12. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007;167:1414-9. Go to original source... Go to PubMed...
    13. ACTIVE investigators: Clopidogrel versus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of vascular Events (ACTIVE W). Lancet 2006;367: 1903-12. Go to original source...
    14. Hylek EM. Strategy of anticoagulation therapy in Boston area. ESC Congress 2008, Munich, 1 September 2008.
    15. Halperin JL. Ximelagatran compared with warfarin for prevention of tromboembolism in patients with nonvalvular atrial fibrillation. SPORTIF III and V. Am Heart J 2003;146:431-8. Go to original source... Go to PubMed...
    16. Madden J. Resection of the left auricular appendix. JAMA 1948;140:769-72. Go to original source...
    17. Katz ES, Tsiamtsiouris T, Applebaum RM, et al. Surgical left atrial appendage ligationis frequently incomplete: a transesophageal study. J Am Coll Cardiol 2000;36: 468-71. Go to original source... Go to PubMed...
    18. Neužil P, Černý Š, Pirk J, a spol. Operace MAZE: jaká je realita chirurgické léčby fibrilace síní v České republice? Cor Vasa 2007;49:67-70.
    19. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:406-26. Go to original source...
    20. Barnett SD, Ad N. Surgical ablation as a treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg 2006;131:1029-35. Go to original source... Go to PubMed...
    21. Oral H, Knight BP, Ozaydin M, et al. Clinical significance of early recurences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 2002;40:100-4. Go to original source... Go to PubMed...
    22. Papppone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-97. Go to original source... Go to PubMed...
    23. Balckshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-9. Go to original source... Go to PubMed...
    24. Stroke Prevention in Atrial Fibrillation: Transesophageal echocardiographic correletes of tromboembolism in high-risk subjects with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-47. Go to original source... Go to PubMed...
    25. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002;105:1887-9. Go to original source... Go to PubMed...
    26. Neužil P, Reddy V, Mráz T, a spol. Katetrizační uzávěr ouška levé síně (PLAATO) u nemocných s fibrilací síní a vysokým rizikem tromboembolických komplikací. Cor Vasa 2005;47:289-92.
    27. Gage BF, Waterman AD, Sahnnon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National registry of Atrial Fibrillation. JAMA 2001;285:2864-70. Go to original source... Go to PubMed...
    28. Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians' reported use of anticoagulation therapy in atrial fibrillation: a cross-sectional survey. Clin Ther 2003;25:1750-64. Go to original source... Go to PubMed...
    29. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5. Go to original source... Go to PubMed...
    30. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003;60:417-22. Go to original source... Go to PubMed...
    31. Block PC. Watching the Watchman. J Am Coll Cardiol 2007;49:1496-7. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes